Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学TLS Induction by Immunotherapy

Rebeca Kennedy

MD, PhD

🏢Dana-Farber Cancer Institute / Harvard Medical School🌐USA

Associate Professor of Medical Oncology

45
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Rebeca Kennedy investigates whether checkpoint inhibitors and combination immunotherapies can induce tertiary lymphoid structures within tumors. Her translational program integrates serial tumor biopsies with immune profiling during therapy. She focuses on melanoma and other immune responsive tumors.

Share:

🧪Research Fields 研究领域

immunotherapy
tertiary lymphoid structures
melanoma
clinical trials
tumor biopsies

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Rebeca Kennedy 的研究动态

Follow Rebeca Kennedy's research updates

留下邮箱,当我们发布与 Rebeca Kennedy(Dana-Farber Cancer Institute / Harvard Medical School)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment